BIOZYM MEDICAL AS
Operating
Fremstilling/salg av medisinske produkter og tjenester, og andre
produkter som naturlig faller sammen med dette, herunder å delta
i andre selskaper med lignende virksomhet, kjøp og salg av aksjer,
eller på annen måte gjøre seg interessert i andre foretagender.
Tilby forskjellige medisinske tjenester innen medisinske tester,
diagnostikk og klinisk virksomhet i samarbeide med andre selskaper i
samme bransjer.
Organization
- Chairman of the board
- OE
Olav Espeland1964
- Years since formation
- 17 years
- since Mar 10, 2009
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 38,000
- 1 share class
- Total number of shareholders
- 2
- persons
- Belongs to group of
Financials
- Annual total result 2025
- -279,448
- NOK
- Total equity 2025
- 69,994
- NOK
Last update: Jul 2, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
OE 1964 | Chairman | 95 % directly |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
OE 1964 | Chairman | 95 % directly |
ME | - | 5 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
OE 1964 | Ordinary shares | 36,100 | 95 % |
ME | Ordinary shares | 1,900 | 5 % |
Shares owned by the BIOZYM MEDICAL AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 111,385 | 98.21 % | |
| Ordinary shares | 10,000 | 10 % | |
| NO0010786809 | 4,690 | 0.18 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2025: NOK 0Operating profit 2025: NOK -3,918Employees: 0
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 18,729 | 11,900 | 121,276 | 242,846 |
Annual Total Result | -279,448 | -264 | -53,919 | -65,614 | -305,186 |
Total assets | 365,998 | 705,382 | 693,916 | 786,143 | 1,132,133 |
Total liabilities | 296,003 | 355,939 | 344,209 | 382,518 | 662,894 |
Total equity | 69,994 | 349,442 | 349,707 | 403,625 | 469,239 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 0 | 18,729 | 11,900 | 121,276 | 242,846 |
Total operating costs | 3,918 | 18,993 | 78,893 | 273,030 | 558,426 |
Operating result | -3,918 | -264 | -66,993 | -151,754 | -315,580 |
Financial income/costs | 0 | 0 | 0 | 67,634 | -24,268 |
Profit before tax | -3,918 | -264 | -66,993 | -84,120 | -339,848 |
Total tax & extraordinary income/cost | 275,530 | 0 | -13,074 | -18,506 | -34,662 |
Annual Total Result | -279,448 | -264 | -53,919 | -65,614 | -305,186 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 353,630 | 406,418 | 406,418 | 616,086 | 633,580 |
Total current assets | 12,367 | 298,964 | 287,498 | 170,057 | 498,553 |
Total assets | 365,998 | 705,382 | 693,916 | 786,143 | 1,132,133 |
Short term debt | 296,003 | 355,939 | 344,209 | 382,518 | 662,894 |
Long term debt | 0 | 0 | 0 | 0 | 0 |
Total liabilities | 296,003 | 355,939 | 344,209 | 382,518 | 662,894 |
Contributed capital | 380,000 | 380,000 | 380,000 | 380,000 | 380,000 |
Retained earnings | -310,006 | -30,558 | -30,293 | 23,625 | 89,239 |
Total equity | 69,994 | 349,442 | 349,707 | 403,625 | 469,239 |
Total equity and liabilities | 365,998 | 705,381 | 693,916 | 786,143 | 1,132,133 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises